BioSpace News Archive

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, is pleased to announce the Company’s ordinary shares have commenced trading on The Nasdaq Capital Market under the ticker symbol “MYNZ”.

Orthogon Therapeutics LLC, a drug development company focused on designing innovative antivirals and anti-infective therapeutics, announced that it has raised an $8M round from a leading syndicate of US based healthcare Angels to advance its pipeline of first-in-class drug assets.

Eton Pharmaceuticals, Inc (Nasdaq: ETON) and Azurity Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved EPRONTIA™ (topiramate) oral solution, 25mg/mL.

The U.S. medical display market has been anticipated to experience significant growth avenues in the upcoming years.

The monoclonal antibody therapeutics market will observe promising during the forecast period of 2016-2024 due to the rising prevalence of chronic diseases around the world.

Products in the global medical pendant market are used by healthcare and medical professionals in order to maintain an efficient workflow through positioning of various essential objects as well as medical devices during the performance of surgeries or other medical procedures.

Royal Philips, a global leader in health technology, announced that it has signed an agreement to acquire Cardiologs, a France-based medical technology company focused on transforming cardiac diagnostics using artificial intelligence and cloud technology.

iOnctura SA, a clinical stage oncology company targeting core resistance and relapse mechanisms at the tumor-stroma-immune interface, announces it has fully enrolled the metastatic uveal melanoma expansion cohort of the DIONE-01 study evaluating iOnctura’s lead compound, the selective PI3Kδ inhibitor IOA-244.

Moberg Pharma AB has entered into a collaboration with Allderma AB for the launch of MOB-015 in Sweden, Norway and Denmark.

Myovant Sciences, a healthcare company focused on redefining care for women and for men, announced the appointment of Nancy Valente, M.D. as an independent member of the company’s Board of Directors.